Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

i(8)(q10) in ALL

Written2017-06Adriana Zamecnikova
Kuwait Cancer Control Center, Department of Hematology, Laboratory of Cancer Genetics, Kuwait; annaadria@yahoo.com

Abstract Isochromosomes are nonrandom chromosomal anomalies in acute lymphoblastic leukemia (ALL), but relatively few patients ALL and i(8)(q10) have been reported. In the majority of cases, i(8)(q10) was part of complex karyotypes, suggesting that it is a secondary chromosomal abnormality in ALL associated with clonal evolution.

Keywords Isochromosome; Acute lymphoblastic leukemia; Chromosome gain; Clonal evolution.

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424
ICD-Morpho 9861/3 AML with mutated NPM1; AML with mutated CEBPA; Acute myeloid leukaemia, NOS
ICD-Morpho 9837/3 T lymphoblastic leukaemia/lymphoma
ICD-Morpho 9808/3 Mixed phenotype acute leukaemia, B/myeloid, NOS 152
Atlas_Id 2052
 
  Partial karyotypes with isochchromosome i(8)(q10) (A). Fluorescence in situ hybridization with LSI MYC probe hybridizing to 8q24 (Vysis/Abott Molecular, US) showing end-to-end joining of homologous chromosomes 8 at the telomeres (B). It can be hypothesized that telomeric fusion of homologous chromosomes can promote creation of an unstable dicentric chromosome potentially causing an unbalanced translocation product. However, the precise consequences of telomere fusion events and their role in formation of isochromosomes remain unclear.

Clinics and Pathology

Disease Acute lymphoblastic leukemia
Phenotype / cell stem origin Associated with B-lineage immunophenotype with exception of 1 chronic myeloid leukaemia (CML) with lymphoid blast crisis of B-cell type who developed a secondary T-cell ALL (Dawson et al., 1999) case and 2 biphenotypic leukemia (Sulak et al.,1990; Saikevich et al., 1991) patients.
Epidemiology At least 40 reported cases (21 males, 19 females aged 0 to 85 years; median age 17 years) were described. Nearly half the cases were children: 2 female infants (O'Malley et al., 1988; Pui et al., 1991) and 12 pediatric cases aged 0 to 15 years (Pollak & Hagemeijer 1987; Krance et al., 1992; Pui et al., 1992; Rafi et al., 2000; An et al., 2008; Suenobu et al., 2010; Chapiro et al., 2011; Harrison et al., 2014; Olsson et al., 2015; Yasuda et al., 2016; Zhang et al., 2016) or young adults aged 17 to 24 years old ( Mossafa et al., 1994; Tang et al., 1998; Jarosova et al., 2000; Soriani et al., 2011; Harrison et al., 2014; Safavi et al., 2015) (Table 1).
46,idem,t(9;10)(p13;q22) or t(9;10) (p22;q24) 1.Pollak & Hagemeijer 1987; 2.O'Malley et al., 1988; 3.Sulak et al.,1990; 4.Kageyama et al., 1991; 5.Pui et al., 1991; 6.Saikevich et al., 1991; 7.Krance et al., 1992; 8.Pui et al., 1992; 9.Dewald et al., 1993; 10.Tuszynski et al., 1993; 11-13.Mossafa et al., 1994; 14.Pirc-Danoewinata et al., 1995; 15.Martineau et al., 1996; 16-17.Rieder et al., 1996; 18.Pabst et al., 1996; 19.Tang et al., 1998; 20.Dabaja et al., 1999; 21.Dawson et al., 1999; 22.Jarosova et al., 2000; 23.Rafi et al., 2000; 24.Rieder et al., 2003; 25.Strefford et al., 2007; 26-27.An et al., 2008; 28.Coyaud et al., 2010; 29.Kowalczyk et al., 2010; 30.Suenobu et al., 2010; 31.Soriani et al., 2011; 32.Chapiro et al., 2013; 33-36.Harrison et al., 2014; 37.Olsson et al., 2015; 38.Safavi et al., 2015; 39.Yasuda et al., 2016; 40.Zhang et al., 2016.
Abbreviations: M, male; F, female.
 Sex/AgeKaryotype
1F/747,XX,del(7)(p?),i(8)(q10),add(9)(p21),ins(9;9)(p21;q12q22),add(14)(q?)
2F/0 46,XX,ins(11;4)/46,idem,del(5)(q15q33)/46,idem,del(5),i(8)(q10)/46,idem,t(2;4)(q33;p16),del(5)/47,idem,+8/

3M/8577-87,XY,-X,-Y,del(5)(q23)x2,i(8)(q10)x2,add(22)(q13),inc        Bilineage or biphenotypic leukemia
4M/5346,XY,+1,der(1;16)(q10;p10),i(8)(q10),t(9;22),-12,der(15)t(12;15)(q12;p11),i(17)(q10),+21
5F/050,XX,+X,+X,i(8)(q10),+10,-20,+21,i(21)(q10)x2,+mar
6M/6343,XY,t(1;9)(q?32;p?24),-2,der(3)t(3;12;17)(p?14;p?11;q?25),-5,i(8)(q10),-12,der(17)t(3;12;17)       Bilineage or biphenotypic leukemia
7M/13 46,XY,i(8)(q10),t(12;17)(p13;q21)
8M/10 46,XY,i(7)(q10),t(9;22)(q34;q11)/48,idem,i(8)(q10),+i(8)(q10)x2
9M49,XY,+4,+8,i(8)(q10)x2,t(9;22)(q34;q11),+der(22)t(9;22)
10F46,XX,t(9;22)(q34;q11)/47,idem,+i(8)(q10)/47,idem,+8,i(8)(q10)x2
11F/60 46,XX,t(9;22)(q34;q11)/46,idem,i(8)(q10)
12M/44 46,XY,i(8)(q10),t(9;22)(q34;q11)
13F/24 46,XX,del(6)(q21q24),i(8)(q10)
14M46,XY,t(14;18)(q32;q21)/46,XY,del(3)(p24),i(8)(q10),del(12)(p12)
15F/42 47,XX,dup(1)(q21q32),add(2)(p11),+7,i(8)(q10),t(8;22)(q24;q11)/47,idem,-dup(1),+trp(1)(q21q32)
16F/36 53,XX,+4,t(9;22)(q34;q11),i(8)(q10),+18,+19,+der(22)t(9;22)x2
17M/5346,XY,t(9;22)(q34;q11)/45,XY,-7,i(8)(q10),ider(9)(q10)t(9;22),der(22)t(9;22)
18M48,XY,i(8)(q10),t(9;22)(q34;q11),+2mar
19F/21 46,XX,i(7)(q10),i(8)(q10),t(9;22)
20M47,Y,-X,-5,-7,+13,-14,-15,+5-6mar/84-91,YY,-X,-X,-4,-4,-5,-5,-7,-7,i(8)(q10),-14,-14,-15,del(22)(q13),+8-10mar
21M/3946,Y,t(X;11),i(7)(q10),dup(8)(q21q22)/46,idem,i(8)(q10)/45,idem,-Y       T-cell ALL after chemotherapy for CML
22M/1745,XY,i(8)(p?),?add(12),-21/45,XY,i(8)(q10),der(12)del(12)(p13)dic(12;21)(p13;p11)
23F/1545,X,-X,-6,del(7)(q21),i(8)(q10),-9,add(9),add(12)(q24),t(12;21)(p13;q22),der(13)t(?6;13)(q12;q32),der(22)t(9;22),+1-2mar
24M/6246,XY,del(1)(q32),i(8)(q10),-9,-10,der(22)t(9;22)(q34;q11),+2mar
25F/4845,X,-X,add(1)(p36),-5,add(6)(q15),i(8)(q10),add(18)(p11) 
26F/14 45,XX,i(8)(q10),dic(9;12)(p11;p11),der(17)t(?X;17)(?q12;?p11)
27F/1346,XX,dic(9;20)(p11;q11),+21/46,idem,i(8)(q10)/46,idem,add(15)(p10)
28M/5146,XY,i(8)(q10),t(9;22)(q34;q11),der(9)t(8;9)(q1?;p12)
29M 47,XY,i(8)(q10),+21c
30F/13 45,XX,t(9;22)(q34;q11),add(10)(q22),-12,der(12)t(12;12)(p13;q13),i(17)(q10)/45,idem,i(8)(q10)
46,X,-X,+1,t(2;16)(p10;q10),+8,-9,t(9;22),add(10),-12,der(12),-13,i(17)(q10),+18,add(19)(p13),del(19)(q?),+21,-22,+mar/47,idem,+8       therapy for neuroblastoma
31M/1748,XY,i(8)(q10),+i(8)(q10)x2,t(9;22)(q34;q11)/49,idem,+der(22)t(9;22)
32M/7 46,XY,t(14;20)(q32;q12)/46,idem,i(8)(q10)
33F/745,XX,dup(1)(q21q32),i(8)(q10),t(9;14)(p22;q11),der(11)t(11;21)(q13;q11)t(21;22)(q22;q11)t(22;22)(q11;q22)
34M46,XY,-21,+r/46,idem,inv(11)(p15q13)/46,idem,i(8)(q10)
35F/19 44,XX,i(8)(q10),-10,add(11)(q23),add(12)(p13),-14,add(14)(q32),add(15)(q25), +16,add(21)(q22),-22,+mar
Prognosis As it occurs rarely as a sole anomaly only in sporadic cases in ALL, thus the prognosis is uncertain; patients with favorable primary aberrations and i(8)(q10) may maintain favorable clinical outcome similar to patients with +8; its combination with unfavorable primary anomaly or complex anomalies may lead to the worst prognosis.

Cytogenetics

Cytogenetics Morphological Sole abnormality in 3 (Kowalczyk et al., 2010; Olsson et al., 2015; Yasuda et al., 2016) and in the stemline, but with other chromosomal changes in 4 patients (Pirc-Danoewinata et al., 1995; Dabaja et al., 1999; Jarosova et al., 2000; Zhang et al., 2016). Double i(8)(q10) was detected in 5 cases (Sulak et al.,1990; Pui et al., 1992; Dewald et al., 1993; Tuszynski et al 1993; Soriani et al., 2011). Complex karyotypes, mainly with occurrence of primary anomalies in the remaining cases. Among them, the most common structural anomaly was t(9;22)(q34;q11) , found in 16 patients (Kageyama et al., 1991; Pui et al., 1992; Dewald et al., 1993; Tuszynski et al., 1993; Mossafa et al., 1994; Rieder et al., 1996; Pabst et al., 1996; Tang et al., 1998; Rafi et al., 2000; Rieder et al., 2003; Coyaud et al., 2010; Suenobu et al., 2010; Soriani et al., 2011; Safavi et al., 2015).

Result of the chromosomal anomaly

Fusion Protein
Oncogenesis Partial chromosome 8q gain resulting from an isochromosome i(8)(q10) is a nonrandom chromosomal anomaly in ALL. It occurs rarely as a sole anomaly and is mainly observed together with primary chromosome aberrations, most frequently with t(9;22)(q34;q11). Therefore, the occurrence of i(8)(q10) in ALL may signal clonal evolution, often associated with disease progression. The consequence of the formation of i(8)(q10) is gain of 8q and loss of 8p, leading to imbalances in gene dosage. As trisomy 8 is among the most common secondary chromosome changes in hematological malignancies, it is likely that gain of 8q, but not the loss of 8p is important in leukemogenesis. In this regard it is interesting to note, that while extra chromosome 8 is a common clonal evolution marker for progression in CML, the occurrence of i(8)(q10) has been only rarely described during CML transformation. While differential diagnosis between blast transformation of CML and Ph1(+) ALL may be difficult, particularly in cases identified initially in blastic crisis, it is possible that i(8)(q10) is a specific secondary anomaly to t(9;22)(q34;q11) in a pre-B immunophenotype ALL.
  

Bibliography

Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer
An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV, Parker H, Griffiths M, Ross FM, Davies T, Hall AG, Harrison CJ, Irving JA, Strefford JC
Proc Natl Acad Sci U S A 2008 Nov 4;105(44):17050-4
PMID 18957548
 
Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature
Chapiro E, Radford-Weiss I, Cung HA, Dastugue N, Nadal N, Taviaux S, Barin C, Struski S, Talmant P, Vandenberghe P, Mozziconacci MJ, Tigaud I, Lefebvre C, Penther D, Bastard C, Lippert E, Mugneret F, Romana S, Bernard OA, Harrison CJ, Russell LJ, Nguyen-Khac F; Groupe Francophone de Cytogénétique Hématologique
Cancer Genet 2013 May;206(5):162-73
PMID 23827691
 
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study
Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, Mugneret F, Talmant P, Pages MP, Lefebvre C, Penther D, Lippert E, Nadal N, Taviaux S, Poppe B, Luquet I, Baranger L, Eclache V, Radford I, Barin C, Mozziconacci MJ, Lafage-Pochitaloff M, Antoine-Poirel H, Charrin C, Perot C, Terre C, Brousset P, Dastugue N, Broccardo C
Blood 2010 Apr 15;115(15):3089-97
PMID 20160164
 
Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications
Dabaja BS, Faderl S, Thomas D, Cortes J, O'Brien S, Nasr F, Pierce S, Hayes K, Glassman A, Keating M, Kantarjian HM
Leukemia 1999 Jun;13(6):869-72
PMID 10360374
 
Secondary T-acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia
Dawson L, Slater R, Hagemeijer A, Langerak AW, Willemze R, Kluin-Nelemans JC
Br J Haematol 1999 Jul;106(1):104-6
PMID 10444170
 
The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL
Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM
Cancer Genet Cytogenet 1993 Nov;71(1):7-14
PMID 8275455
 
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
Harrison CJ, Moorman AV, Schwab C, Carroll AJ, Raetz EA, Devidas M, Strehl S, Nebral K, Harbott J, Teigler-Schlegel A, Zimmerman M, Dastuge N, Baruchel A, Soulier J, Auclerc MF, Attarbaschi A, Mann G, Stark B, Cazzaniga G, Chilton L, Vandenberghe P, Forestier E, Haltrich I, Raimondi SC, Parihar M, Bourquin JP, Tchinda J, Haferlach C, Vora A, Hunger SP, Heerema NA, Haas OA; Ponte di Legno International Workshop in Childhood Acute Lymphoblastic Leukemia
Leukemia 2014 May;28(5):1015-21
PMID 24166298
 
Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia
Jarosová M, Holzerová M, Jedlicková K, Mihál V, Zuna J, Starý J, Pospísilová D, Zemanová Z, Trka J, Blazek J, Pikalová Z, Indrák K
Cancer Genet Cytogenet 2000 Dec;123(2):114-22
PMID 11156736
 
Ph1-positive acute lymphoblastic leukemia associated with an isochromosome 17q
Kageyama T, Takiuchi H, Hasegawa M, Ohyabu H, Horiike S
Int J Hematol 1991 Jun;54(3):257-61
PMID 1747460
 
Structural and numerical abnormalities resolved in one-step analysis: the most common chromosomal rearrangements detected by comparative genomic hybridization in childhood acute lymphoblastic leukemia
Kowalczyk JR, Babicz M, Gaworczyk A, Lejman M, Winnicka D, Styka B, Jaszczuk I
Cancer Genet Cytogenet 2010 Jul 15;200(2):161-6
PMID 20620600
 
t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia
Krance RA, Raimondi SC, Dubowy R, Estrada J, Borowitz M, Behm F, Land VJ, Pullen J, Carroll AJ
Leukemia 1992 Apr;6(4):251-5
PMID 1534130
 
Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding
Martineau M, Clark R, Farrell DM, Hawkins JM, Moorman AV, Secker-Walker LM
Genes Chromosomes Cancer 1996 Sep;17(1):21-30
PMID 8889503
 
Isochromosome 8q: a new recurring secondary anomaly in adults with B-lineage acute lymphoid leukemia
Mossafa H, Huret JL, Brizard A, Guilhot F, Lessard M, Tanzer J
Cancer Genet Cytogenet 1994 Mar;73(1):84-5
PMID 8174082
 
Acute lymphoblastic leukemia with a unique rearrangement between chromosomes 4 and 11
O'Malley DP, Kulkarni R, Oaks MK, Higgins JV
Cancer Genet Cytogenet 1988 Apr;31(2):291-4
PMID 3258177
 
Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1
Olsson L, Albitar F, Castor A, Behrendtz M, Biloglav A, Paulsson K, Johansson B
Genes Chromosomes Cancer 2015 May;54(5):315-25
PMID 25727050
 
Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias
Pabst T, Schwaller J, Bellomo MJ, Oestreicher M, Mühlematter D, Tichelli A, Tobler A, Fey MF
Blood 1996 Aug 1;88(3):1026-34
PMID 8704211
 
Phorbol-12,13-dibutyrate improves the quality of cytogenetic preparation in lymphoid malignancies
Pirc-Danoewinata H, Onderka E, Porenta G, Kundi M, Nowotny H, Schlögl E, Heinz R, Kreiner G, Marosi C
Cancer Genet Cytogenet 1995 Apr;80(2):129-34
PMID 7736430
 
Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders
Pollak C, Hagemeijer A
Leukemia 1987 Jul;1(7):541-8
PMID 3312844
 
Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases
Pui CH, Carroll AJ, Raimondi SC, Schell MJ, Head DR, Shuster JJ, Crist WM, Borowitz MJ, Link MP, Behm FG, et al
Blood 1992 May 1;79(9):2384-91
PMID 1571550
 
Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse
Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J Jr, Crist WM, Behm FG
Blood 1991 Sep 1;78(5):1327-37
PMID 1878594
 
ETV6/CBFA2 fusions in childhood B-cell precursor acute lymphoblastic leukemia with myeloid markers
Rafi SK, El Gebaly H, Qumsiyeh MB
Diagn Mol Pathol 2000 Dec;9(4):184-9
PMID 11129441
 
Cell lineage assignment of cytogenetic findings in acute lymphoblastic leukemia using combined immunomagnetic cell separation and chromosome preparation
Rieder H, Bachmann I, Busch S, Schwartz S, Reckzeh B, Hoelzer D
Haematologica 2003 Nov;88(11):1317-20
PMID 14607762
 
Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia
Rieder H, Ludwig WD, Gassmann W, Maurer J, Janssen JW, Gökbuget N, Schwartz S, Thiel E, Löffler H, Bartram CR, Hoelzer D, Fonatsch C
Br J Haematol 1996 Dec;95(4):678-91
PMID 8982045
 
Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia
Safavi S, Hansson M, Karlsson K, Biloglav A, Johansson B, Paulsson K
Haematologica 2015 Jan;100(1):55-61
PMID 25261097
 
Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology
Saikevych IA, Kerrigan DP, McConnell TS, Head DR, Appelbaum FR, Willman CL
Leukemia 1991 May;5(5):373-82
PMID 2033959
 
Three copies of isochromosome 8q in Ph+ B-cell acute lymphoblastic leukemia
Soriani S, Fedeli F, Molteni A, Grillo G, Tedeschi A, Scarpati B, Campidelli C, Leszl A, Farioli R, De Canal G, Mura MA, Cesana C
Leuk Res 2011 Nov;35(11):e217-9
PMID 21767878
 
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization
Strefford JC, Worley H, Barber K, Wright S, Stewart AR, Robinson HM, Bettney G, van Delft FW, Atherton MG, Davies T, Griffiths M, Hing S, Ross FM, Talley P, Saha V, Moorman AV, Harrison CJ
Oncogene 2007 Jun 21;26(29):4306-18
PMID 17237825
 
Ph+ALL in a pediatric patient with neuroblastoma in infancy
Suenobu S, Handa YS, Kuga S, Kakiuchi T, Akiyoshi K, Imai K, Izumi T
Pediatr Int 2010 Jun;52(3):e147-9
PMID 20723114
 
Biphenotypic acute leukemia in adults
Sulak LE, Clare CN, Morale BA, Hansen KL, Montiel MM
Am J Clin Pathol 1990 Jul;94(1):54-8
PMID 1694392
 
Frequent p53 mutation in relapsed acute lymphoblastic leukemia with cytogenetic instability: a longitudinal analysis
Tang JL, Tien HF, Lin MT, Chen PJ, Chen YC
Anticancer Res 1998 Mar-Apr;18(2B):1273-8
PMID 9615800
 
Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia
Tuszynski A, Dhut S, Young BD, Lister TA, Rohatiner AZ, Amess JA, Chaplin T, Dorey E, Gibbons B
Leukemia 1993 Oct;7(10):1504-8
PMID 8412311
 
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Taniwaki M, Kurokawa M, Morishita S, Fukayama M, Kiyoi H, Miyazaki Y, Naoe T, Mano H
Nat Genet 2016 May;48(5):569-74
PMID 27019113
 
Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project
Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, Wu G, Li Y, Wei L, Iacobucci I, Liu Y, Qu C, Wen J, Edmonson M, Payne-Turner D, Kaufmann KB, Takayanagi SI, Wienholds E, Waanders E, Ntziachristos P, Bakogianni S, Wang J, Aifantis I, Roberts KG, Ma J, Song G, Easton J, Mulder HL, Chen X, Newman S, Ma X, Rusch M, Gupta P, Boggs K, Vadodaria B, Dalton J, Liu Y, Valentine ML, Ding L, Lu C, Fulton RS, Fulton L, Tabib Y, Ochoa K, Devidas M, Pei D, Cheng C, Yang J, Evans WE, Relling MV, Pui CH, Jeha S, Harvey RC, Chen IL, Willman CL, Marcucci G, Bloomfield CD, Kohlschmidt J, Mrózek K, Paietta E, Tallman MS, Stock W, Foster MC, Racevskis J, Rowe JM, Luger S, Kornblau SM, Shurtleff SA, Raimondi SC, Mardis ER, Wilson RK, Dick JE, Hunger SP, Loh ML, Downing JR, Mullighan CG; St
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia Nat Genet
PMID 27776115
 

Citation

This paper should be referenced as such :
Zamecnikova A
i(8)(q10) in ALL;
Atlas Genet Cytogenet Oncol Haematol. in press
On line version : http://AtlasGeneticsOncology.org/Anomalies/i8q10ALLID2052.html


Translocations implicated (Data extracted from papers in the Atlas)

 i(8)(q10)

External links

Mitelman databasei(8)(q10) [Case List]    i(8)(q10) [Association List] Mitelman database (CGAP - NCBI)
arrayMapMorph ( 9861/3) - arrayMap (UZH-SIB Zurich)  [auto + random 100 samples .. if exist ]   [tabulated segments]
arrayMapMorph ( 9837/3) - arrayMap (UZH-SIB Zurich)  [auto + random 100 samples .. if exist ]   [tabulated segments]
arrayMapMorph ( 9808/3) - arrayMap (UZH-SIB Zurich)  [auto + random 100 samples .. if exist ]   [tabulated segments]
 
 
Disease databasei(8)(q10) in ALL
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Jun 30 11:22:21 CEST 2017


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.